LAPLACE INTERVENTIONAL
Laplace developing Transcatheter Tricuspid Valve Technology to offer an increase in life expectancy and an improvement to the quality of life to worldwide patients with tricuspid regurgitation.
LAPLACE INTERVENTIONAL
Industry:
Health Care Medical Device
Founded:
2020-01-01
Address:
Plymouth, Minnesota, United States
Country:
United States
Status:
Active
Contact:
6122137388
Total Funding:
7.9 M USD
Similar Organizations
Linemed
Linemed is a medical device company.
Simply ID
Simply ID is a medical device company.
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Advisors List
Board_member
2021-09-01
Current Employees Featured
Ramji Iyer Founder and CEO @ Laplace Interventional
Founder and CEO
Founder
Investors List
Shangbay Capital
Shangbay Capital investment in Series A - Laplace Interventional
Mayo Clinic
Mayo Clinic investment in Series A - Laplace Interventional
gBETA Medtech
gBETA Medtech investment in Non Equity Assistance - Laplace Interventional
gbeta
gbeta investment in Non Equity Assistance - Laplace Interventional
More informations about "Laplace Interventional"
Laplace Interventional
Laplace Interventional Inc. is a medical device company in Plymouth, MN, USA. Laplace Interventional’s investigational device could potentially offer an increase in life expectancy and/or an improvement to quality of life to several patients …See details»
Laplace Interventional - Crunchbase Company Profile …
Laplace Interventional closed its last funding round on Jul 24, 2023 from a Series B round. Who are Laplace Interventional 's competitors? Alternatives and possible competitors to Laplace Interventional may include SyMap Medical , NuVera …See details»
Laplace Interventional Company Profile 2025: …
Laplace Interventional General Information Description. Provider of a transcatheter tricuspid valve intended to offer an increase in life expectancy. The company's device is a prosthetic valve that is delivered through a minimally …See details»
Laplace Interventional - LinkedIn
Laplace Interventional | 586 followers on LinkedIn. Developing a novel transcatheter treatment to improve the lives of patients suffering Tricuspid Regurgitation | Laplace Interventional is ...See details»
Laplace Interventional Company Profile: Overview and Full News …
Laplace Interventional, based in Plymouth, Minnesota, is a medical device company focused on developing innovative solutions for patients diagnosed with Tricuspid Regurgitation (TR). Their …See details»
Laplace Interventional - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 24, 2023: Series B - …See details»
Up & Running with Ramji Iyer, CEO of Laplace …
Mar 9, 2020 Ramji Iyer is the founder and CEO of Laplace Interventional, which is developing a unique solution to tricuspid regurgitation. In his last role, Ramji was the Senior Director of R&D at LivaNova (Caisson Interventional) and led …See details»
Laplace Interventional - Products, Competitors, Financials, …
Laplace Interventional's TTVR system is designed for procedural simplicity and is delivered through the patient's vasculature without requiring a high risk open-heart surgery. "TMC is …See details»
Laplace Interventional Inc. Company Profile | Plymouth, MN ...
Find company research, competitor information, contact details & financial data for Laplace Interventional Inc. of Plymouth, MN. Get the latest business insights from Dun & Bradstreet.See details»
Laplace Interventional - VentureRadar
Laplace Interventional provides a device that is designed to offer an increase in life expectancy and an improvement to the quality of life to patients diagnosed with Tricuspid Regurgitation …See details»
Laplace Interventional - Updates, News, Events, Signals & Triggers
Laplace Interventional may be growing as it has announced a successful first in human procedure in an early feasibility study of its transcatheter tricuspid valve replacement device. This …See details»
Laplace's Tricuspid Valve Replacement Device Marks Successful …
Feb 26, 2024 Minnesota based Laplace Interventional announced the successful completion of its first-in-human (FIH) procedure with its Laplace Transcatheter Tricuspid Valve Replacement …See details»
Laplace Interventional, Inc. in Plymouth, Minnesota - EIN TaxId
Laplace Interventional, Inc. is a corporation in Plymouth, Minnesota. The employer identification number (EIN) for Laplace Interventional, Inc. is 852339037. EIN for organizations is …See details»
Laplace Interventional secures funding for clinical testing of ...
Aug 2, 2023 Laplace Interventional’s device is designed to offer an increase in life expectancy and an improvement to the quality of life to patients diagnosed with tricuspid regurgitation …See details»
Series B - Laplace Interventional - 2023-07-24 - Crunchbase
Jul 24, 2023 Laplace Interventional raised $12900000 on 2023-07-24 in Series B. Shangbay Capital Best-in-class investments mainly in the U.S. medical devices technology, as well as …See details»
Laplace Interventional Inc. Announces Successful First in Human ...
Feb 26, 2024 Laplace Interventional Founder and CEO, Ramji Iyer, PhD said " On behalf of the Laplace team, I would like to congratulate Dr. Waggoner, Dr. Makdisi and the entire team at …See details»
Laplace completes first human procedure with TTVR system
Feb 26, 2024 Last year, Laplace Interventional successfully closed a $12.9m Series B financing round to advance its strategy for its first-in-human trial of its transcatheter valve system. The …See details»
Laplace Interventional Closes Financing for Development of ...
Jul 24, 2023 Laplace Interventional advised that the device is in the early stage of its development phase and is not approved or cleared by the FDA or any other regulatory body in …See details»
Laplace Interventional - Tech Stack, Apps, Patents & Trademarks
Laplace is a medical device company that develops transcatheter tricuspid valve technology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …See details»
Laplace Interventional Inc. Announces $7.9M Series A for its ...
Sep 2, 2021 Laplace Interventional’s device aims to offer an increase in life expectancy and an improvement to the quality of life to several patients worldwide diagnosed with Tricuspid …See details»